Evaluating elimination of mother-to-child transmission of HIV in Suriname : a mixed method study
Objectives: To evaluate the cascade of care for the elimination of mother-to-child-transmission of human immunodeficiency virus (HIV) in Suriname and identify sociodemographic and clinical factors preventing transmission to exposed infants.
Methods: A mixed-methods study design was used. Antenatal care data from the 2018 cross-sectional multi-indicator cluster survey on 1 026 women aged 15-49 years who had had a live birth in the previous 2 years were used. Furthermore, national data on a cohort of 279 mothers with HIV and their 317 infants born from 2016 to 2018 were evaluated. Additionally, 13 cases of mother-to-child-transmission of HIV were reviewed.
Results: In 89.3% of cases, no mother-to-child HIV transmission occurred. Early cascade steps show that 28.4% of women had unmet family planning needs, 15% had no antenatal visits, 8% delivered outside a health facility, and 71.5% received an HIV test during antenatal care. Of the pregnant women with HIV, 84.2% received antiretroviral therapy, while 95.5% of their infants received HIV prophylactic treatment. Receiving antiretroviral therapy for the mother (odds ratio (OR) 45.4, 95% confidence interval (CI) 9.6-215.3) and the child (OR 145.7, 95% CI 14.4-1477.4) significantly increased the odds of a negative HIV test result in infants. Conversely, living in the interior decreased the odds (OR 0.2, 95% CI 0.4-0.7) compared with urban living.
Conclusions: HIV medication for mothers with HIV and their infants remains key in the prevention of mother-to-child-transmission of HIV. Early prenatal care with follow-up should be strengthened in Suriname.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Revista panamericana de salud publica = Pan American journal of public health - 47(2023) vom: 28., Seite e159 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stijnberg, Deborah [VerfasserIn] |
---|
Links: |
---|
Themen: |
HIV |
---|
Anmerkungen: |
Date Revised 20.12.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.26633/RPSP.2023.159 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366022148 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366022148 | ||
003 | DE-627 | ||
005 | 20231227134949.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.26633/RPSP.2023.159 |2 doi | |
028 | 5 | 2 | |a pubmed24n1233.xml |
035 | |a (DE-627)NLM366022148 | ||
035 | |a (NLM)38111520 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stijnberg, Deborah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluating elimination of mother-to-child transmission of HIV in Suriname |b a mixed method study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.12.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Objectives: To evaluate the cascade of care for the elimination of mother-to-child-transmission of human immunodeficiency virus (HIV) in Suriname and identify sociodemographic and clinical factors preventing transmission to exposed infants | ||
520 | |a Methods: A mixed-methods study design was used. Antenatal care data from the 2018 cross-sectional multi-indicator cluster survey on 1 026 women aged 15-49 years who had had a live birth in the previous 2 years were used. Furthermore, national data on a cohort of 279 mothers with HIV and their 317 infants born from 2016 to 2018 were evaluated. Additionally, 13 cases of mother-to-child-transmission of HIV were reviewed | ||
520 | |a Results: In 89.3% of cases, no mother-to-child HIV transmission occurred. Early cascade steps show that 28.4% of women had unmet family planning needs, 15% had no antenatal visits, 8% delivered outside a health facility, and 71.5% received an HIV test during antenatal care. Of the pregnant women with HIV, 84.2% received antiretroviral therapy, while 95.5% of their infants received HIV prophylactic treatment. Receiving antiretroviral therapy for the mother (odds ratio (OR) 45.4, 95% confidence interval (CI) 9.6-215.3) and the child (OR 145.7, 95% CI 14.4-1477.4) significantly increased the odds of a negative HIV test result in infants. Conversely, living in the interior decreased the odds (OR 0.2, 95% CI 0.4-0.7) compared with urban living | ||
520 | |a Conclusions: HIV medication for mothers with HIV and their infants remains key in the prevention of mother-to-child-transmission of HIV. Early prenatal care with follow-up should be strengthened in Suriname | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV | |
650 | 4 | |a Suriname | |
650 | 4 | |a infectious disease transmission, vertical | |
700 | 1 | |a Holband, Suze |e verfasserin |4 aut | |
700 | 1 | |a Charles, Regillio |e verfasserin |4 aut | |
700 | 1 | |a Ulenaers, Dorien |e verfasserin |4 aut | |
700 | 1 | |a Schrooten, Ward |e verfasserin |4 aut | |
700 | 1 | |a Adhin, Malti R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista panamericana de salud publica = Pan American journal of public health |d 1998 |g 47(2023) vom: 28., Seite e159 |w (DE-627)NLM090839609 |x 1680-5348 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2023 |g day:28 |g pages:e159 |
856 | 4 | 0 | |u http://dx.doi.org/10.26633/RPSP.2023.159 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2023 |b 28 |h e159 |